Open Biosystems' portfolio of RNAi resources include shRNAmir lentiviral and retroviral libraries targeting the entire human and mouse genomes, the RNAi Consortium human and mouse lentiviral shRNA libraries as well as RNAi collections targeting Drosophila, C. elegans and Arabidopsis Thaliana. Participation in the Open Access RNAi program provides researchers the most complete and flexible access to their choice of these rapidly evolving RNAi technologies.
About Open Access RNAi
The Open Biosystems Open Access RNAi Program gives entire academic systems, including multiple campuses, access to the company's advanced shRNA libraries, priority technical support, and continued access to all extensions of existing libraries as well as library upgrades. In this manner, Open Biosystems supports academic research without imposing heavy financial burdens on individual labs. The program is customizable and can be tailored to fit the diverse needs of research institutions worldwide. Complete details can be found at http://www.openbiosystems.com/OpenAccessRNAi
About Open Biosystems
Open Biosystems, Inc. develops, manufactures and markets genomic
research tools to scientists and researchers in corporate, academic and
government laboratories. These research tools provide investigators with
standardized high-quality genes, RNAi and antibodies for interrogating gene
function in relation to oncology, neuroscience and metabolic disorders.
Founded in 2001, Open Biosystems is headquartered in Huntsville, Alabama.
For more information and details for ordering, please visit
| SOURCE Open Biosystems, Inc. Copyright©2008 PR Newswire. All rights reserved |